Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03446118 · ClinicalTrials.gov registry record · NA
MRI to Assess Fibrosis in Eosinophilic Esophagitis Patients
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03446118: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT03446118 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03446118, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Can an MRI detect and monitor the inflammatory and fibrotic possess in patients with Eosinophilic Esophagitis
Primary Outcome
At 5,15 and 25 cm above the gastroesophageal junction and in areas of obvious esophageal thickness, digitized areas of inflammation and fibrosis will be measured individually and as a proportion of overall esophageal diameter in that area before and after steroid treatment.
Interventions
- DIAGNOSTIC_TEST MRI to detect inflammation and fibrosis in subjects with EoE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2019-04-15 |
| Phase | NA |
Why NCT03446118 stopped before completion
NCT03446118 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which MRI to detect inflammation and fibrosis in subjects with EoE is the first listed.
NCT03446118 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03446118 about?
NCT03446118 is a clinical study titled "MRI to Assess Fibrosis in Eosinophilic Esophagitis Patients". Can an MRI detect and monitor the inflammatory and fibrotic possess in patients with Eosinophilic Esophagitis
What is the current status of trial NCT03446118?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2017-03-01. Estimated completion is 2019-04-15.
What interventions are being tested in trial NCT03446118?
The interventions under investigation include: MRI to detect inflammation and fibrosis in subjects with EoE (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03446118?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03446118's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI